Here begins the text.
What's New (FY2016)
March 29, 2017The 2nd Japan - India Medical Products Regulation Symposium
March 21, 2017Revisions of PRECAUTIONS: Lamotrigine, etc. posted
March 15, 2017Report of the PMDA-ATC Pharmacovigilance Seminar 2017
March 15, 2017Report of the PMDA-ATC GMP Inspection Seminar 2016
March 15, 2017Report of the PMDA-ATC MRCT Seminar 2017
February 10, 2017Report of the PMDA-ATC Medical Devices Seminar 2016
February 9, 2017“Rational Medicine” Initiative (February 9, 2017)
January 23, 2017ICH Q12 WG
January 16, 2017The APEC-LSIF-RHSC MRCT/GCP inspection Workshop (Updated program etc.)
January 5, 2017The 4th Thailand-Japan Symposium
January 4, 2017Information about Columns for JP draft monographs (Crude drug) posted
December 15, 2016PMDA joins International program to rationalize GMP Inspections of API manufacturers (November 25, 2016)
November 16, 20164th Joint Conference of Taiwan and Japan on Medical Products Regulation posted
November 11, 2016PMDA-ATC Pharmacovigilance Seminar 2017
October 31, 2016PMDA-ATC MRCT Seminar 2017
October 11, 2016Report of the Japanese Pharmacopoeia 130th Anniversary Symposium (Held on September 15, 2016)
September 16, 2016Report of the PMDA-ATC Pharmaceuticals Review Seminar 2016
September 9, 2016PMDA-ATC GMP Inspection Seminar 2016
September 7, 2016JP Drafts (September, 2016) posted
August 25, 2016PMDA-ATC Medical Devices Seminar 2016
August 4, 2016PMDA-ATC Pharmaceuticals Review Seminar 2016 in Bangkok, Thailand
June 8, 2016JP Drafts (June, 2016) posted
May 27, 2016PMDA-ATC Pharmaceuticals Review Seminar 2016
April 18, 2016Investigation results: Mycophenolate Mofetil posted
April 14, 2016Report of the International Regulatory Forum of Human Cell Therapy and Gene Therapy Products